Pompidou Group
Pompidou Group
The Pompidou Group, officially known as the Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs, is an intergovernmental body established in 1971. It operates under the auspices of the Council of Europe and focuses on addressing issues related to drug policy, drug abuse, and illicit drug trafficking.
History[edit | edit source]
The Pompidou Group was initiated by the late French President Georges Pompidou in 1971. It was initially a forum for seven European countries to discuss and develop policies to combat drug abuse and trafficking. Over the years, the group has expanded its membership and now includes 41 member states.
Objectives[edit | edit source]
The primary objectives of the Pompidou Group are to:
- Promote a balanced approach to drug policy, integrating both demand and supply reduction strategies.
- Facilitate the exchange of information and best practices among member states.
- Support the development of effective drug policies through research and training.
- Foster international cooperation in combating drug-related issues.
Structure[edit | edit source]
The Pompidou Group operates through several bodies, including:
- The Ministerial Conference, which meets every three years to set the strategic direction and priorities.
- The Permanent Correspondents, who are senior officials from member states responsible for implementing the group's work program.
- Various expert committees and working groups that focus on specific aspects of drug policy and practice.
Activities[edit | edit source]
The Pompidou Group engages in a wide range of activities, including:
- Conducting research and publishing reports on drug-related issues.
- Organizing conferences, seminars, and training programs for policymakers and practitioners.
- Providing technical assistance and support to member states in developing and implementing drug policies.
- Promoting the integration of human rights and public health perspectives into drug policy.
Membership[edit | edit source]
Membership in the Pompidou Group is open to all member states of the Council of Europe. Non-member states and international organizations can also participate as observers. The group's inclusive approach allows for a broad exchange of ideas and experiences.
Achievements[edit | edit source]
The Pompidou Group has made significant contributions to the field of drug policy, including:
- Developing the European Drug Prevention Prize, which recognizes innovative drug prevention projects.
- Establishing the Mediterranean Network, which fosters cooperation between European and Mediterranean countries on drug-related issues.
- Publishing influential reports and guidelines on topics such as drug treatment, prevention, and law enforcement.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD